Letter to the editor

This publication has 6 references indexed in Scilit:

• An examination of the results of the EVIDENCE, INCOMIN, and phase III studies of interferon beta products in the treatment of multiple sclerosis
  Clinical Therapeutics, 2003
• Randomized, comparative study of interferon β-1a treatment regimens in MS
  Neurology, 2002
• Every-other-day interferon beta-1b versus once-weekly interferon beta-1a for multiple sclerosis: results of a 2-year prospective randomised multicentre study (INCOMIN)
  The Lancet, 2002
• Disease modifying therapies in multiple sclerosis: Subcommittee of the American Academy of Neurology and the MS Council for Clinical Practice Guidelines [RETIRED]
  Neurology, 2002
• Intramuscular interferon beta‐1a for disease progression in relapsing multiple sclerosis
  Annals of Neurology, 1996
• THE NATURAL HISTORY OF MULTIPLE SCLEROSIS: A GEOGRAPHICALLY BASED STUDY
  Brain, 1991